Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.

Literature DB >> 18309145

A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.

Sean I Savitz¹, Wolf-Rüdiger Schäbitz.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18309145 DOI： 10.1161/STROKEAHA.107.504415

Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Antioxidant strategies in neurocritical care.

Authors: Khalid A Hanafy; Magdy H Selim
Journal: Neurotherapeutics Date: 2012-01 Impact factor: 7.620

Review 2. Targeting the neurovascular unit for treatment of neurological disorders.

Authors: Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal: Pharmacol Ther Date: 2010-12-21 Impact factor: 12.310

Review 3. Nitrones as therapeutics.

Authors: Robert A Floyd; Richard D Kopke; Chul-Hee Choi; Steven B Foster; Sabrina Doblas; Rheal A Towner
Journal: Free Radic Biol Med Date: 2008-08-29 Impact factor: 7.376

4. Post-acute delivery of memantine promotes post-ischemic neurological recovery, peri-infarct tissue remodeling, and contralesional brain plasticity.

Authors: Ya-Chao Wang; Eduardo H Sanchez-Mendoza; Thorsten R Doeppner; Dirk M Hermann
Journal: J Cereb Blood Flow Metab Date: 2016-07-20 Impact factor: 6.200

5. The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregeneration.

Authors: Thorsten R Doeppner; Jens R Pehlke; Britta Kaltwasser; Jana Schlechter; Ertugrul Kilic; Mathias Bähr; Dirk M Hermann
Journal: J Cereb Blood Flow Metab Date: 2015-07-29 Impact factor: 6.200

A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.

Review 1. Antioxidant strategies in neurocritical care.

Review 2. Targeting the neurovascular unit for treatment of neurological disorders.

Review 3. Nitrones as therapeutics.

4. Post-acute delivery of memantine promotes post-ischemic neurological recovery, peri-infarct tissue remodeling, and contralesional brain plasticity.

5. The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregeneration.

Review 6. Lipoxygenase: an emerging target for stroke therapy.

7. A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia.

Review 8. Inductive and Deductive Approaches to Acute Cell Injury.

9. Oncostatin M Confers Neuroprotection against Ischemic Stroke.

Review 10. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.